DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Mesalazine

Mesalazine

  • PACKAGE LEAFLET: INFORMATION for the USER Asacol® 800Mg MR Tablets (Mesalazine) Read All of This Leaflet Carefully Before You S

    PACKAGE LEAFLET: INFORMATION for the USER Asacol® 800Mg MR Tablets (Mesalazine) Read All of This Leaflet Carefully Before You S

  • Salofalk®) in an Open Study of 20 Patients with Ankylosing Spondylitis

    Salofalk®) in an Open Study of 20 Patients with Ankylosing Spondylitis

  • Development of Mesalazine Microspheres for Colon Targeting

    Development of Mesalazine Microspheres for Colon Targeting

  • Recent Advances in Mesalamine Colonic Delivery Systems Mohammad F

    Recent Advances in Mesalamine Colonic Delivery Systems Mohammad F

  • Physicochemical Compatibility Investigation of Mesalazine and Folic Acid Using Chromatographic and Thermoanalytical Techniques

    Physicochemical Compatibility Investigation of Mesalazine and Folic Acid Using Chromatographic and Thermoanalytical Techniques

  • Mesalazine Improves Replication Fidelity in Cultured Colorectal Cells

    Mesalazine Improves Replication Fidelity in Cultured Colorectal Cells

  • (5-ASA): a Unique Anti-Inflammatory Salicylate

    (5-ASA): a Unique Anti-Inflammatory Salicylate

  • Formulation of Ketorolac Tromethamine for Controlled Release in Gastrointestinal and Colonic Delivery System

    Formulation of Ketorolac Tromethamine for Controlled Release in Gastrointestinal and Colonic Delivery System

  • PENTASA® Is Addictive

    PENTASA® Is Addictive

  • Pharmaceuticals As Environmental Contaminants

    Pharmaceuticals As Environmental Contaminants

  • Oral Mesalazine for Inflammatory Bowel Disease This Leaflet Is About the Use of Oral (By Mouth) Mesalazine for Inflammatory Bowel Diseases

    Oral Mesalazine for Inflammatory Bowel Disease This Leaflet Is About the Use of Oral (By Mouth) Mesalazine for Inflammatory Bowel Diseases

  • (12) United States Patent (10) Patent No.: US 8,026,285 B2 Bezwada (45) Date of Patent: Sep

    (12) United States Patent (10) Patent No.: US 8,026,285 B2 Bezwada (45) Date of Patent: Sep

  • Delayed Antiviral Plus Immunomodulator Treatment Still Reduces Mortality in Mice Infected by High Inoculum of Influenza A/H5N1 Virus

    Delayed Antiviral Plus Immunomodulator Treatment Still Reduces Mortality in Mice Infected by High Inoculum of Influenza A/H5N1 Virus

  • Determination of Mesalazine Using Terbium Rare Earth Ions As A

    Determination of Mesalazine Using Terbium Rare Earth Ions As A

  • Nsaids) and Mesalazine in the Chemoprevention of Colorectal Cancer

    Nsaids) and Mesalazine in the Chemoprevention of Colorectal Cancer

  • Bipolymeric Pectin Millibeads Doped with Functional Polymers As Matrices for the Controlled and Targeted Release of Mesalazine

    Bipolymeric Pectin Millibeads Doped with Functional Polymers As Matrices for the Controlled and Targeted Release of Mesalazine

  • Environmentally Classified Pharmaceuticals 2014-2015

    Environmentally Classified Pharmaceuticals 2014-2015

  • Neemmc Guidelines for Tablet Crushing and Administration Via Enteral Feeding Tubes

    Neemmc Guidelines for Tablet Crushing and Administration Via Enteral Feeding Tubes

Top View
  • A Differential Effect of 5-ASA and Nsaids on Colonic Epithelial Cell Proliferation ANNALS of GASTROENTEROLOGY 2009, 22(2):97-101X Xx X97
  • Stembook 2018.Pdf
  • Pharmacogenomic Associations Tables
  • Different Kinetic Spectrophotometric Methods for the Determination of Mefenamic Acid, Niflumic Acid, Mesalazine and Sulfasalazine in Their Pharmaceutical Formulation
  • Study of Drug-Drug and Drug-Food Interactions of Mesalazine Through FTIR and DSC
  • Antioxidant Therapy in Inflammatory Bowel Diseases
  • Nsaids and Acute Pancreatitis: a Systematic Review
  • Comparison of Delayed Release 5 Aminosalicylic Acid (Mesalazine) and Sulphasalazine in the Treatment of Mild to Moderate Ulcerative Colitis Relapse
  • Extensive Lichenoid Drug Eruption Due to Glyburide: a Case Report and Review of the Literature
  • EN GAST IND.Pdf
  • Glimepiride Sandoz® Glimepiride Tablets
  • MEZAVANT® Mesalazine 1.2 G, Gastro-Resistant, Prolonged Release Tablets
  • Guidelines for the Management of Inflammatory Bowel Disease in Adults
  • Ulcerative Colitis Information for Patients
  • A Classification of Drug Substances According to Their Mechanism of Action REVIEW
  • Ketorolac Tromethiamine Tablets Targeting to Colon Through Microbial Degradation and Ph Dependence Development and Roentogenographic Studies
  • Interactions with Experimental COVID-19 Therapies
  • Salicylate Induced Exacerbation of Ulcerative Colitis


© 2024 Docslib.org    Feedback